company background image
MDX logo

MedX Health TSXV:MDX Stock Report

Last Price

CA$0.085

Market Cap

CA$23.0m

7D

13.3%

1Y

41.7%

Updated

10 Dec, 2024

Data

Company Financials

MDX Stock Overview

Develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. More details

MDX fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

MedX Health Corp Competitors

Price History & Performance

Summary of all time highs, changes and price drops for MedX Health
Historical stock prices
Current Share PriceCA$0.085
52 Week HighCA$0.11
52 Week LowCA$0.025
Beta1.34
11 Month Change54.55%
3 Month Change88.89%
1 Year Change41.67%
33 Year Change13.33%
5 Year Change-15.00%
Change since IPO-71.67%

Recent News & Updates

Recent updates

Shareholder Returns

MDXCA Medical EquipmentCA Market
7D13.3%-3.7%0.08%
1Y41.7%-13.0%23.2%

Return vs Industry: MDX exceeded the Canadian Medical Equipment industry which returned -13% over the past year.

Return vs Market: MDX exceeded the Canadian Market which returned 23.2% over the past year.

Price Volatility

Is MDX's price volatile compared to industry and market?
MDX volatility
MDX Average Weekly Movement20.4%
Medical Equipment Industry Average Movement14.8%
Market Average Movement8.4%
10% most volatile stocks in CA Market17.8%
10% least volatile stocks in CA Market3.0%

Stable Share Price: MDX's share price has been volatile over the past 3 months compared to the Canadian market.

Volatility Over Time: MDX's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of Canadian stocks.

About the Company

FoundedEmployeesCEOWebsite
1999n/aStephen Lockyerwww.medxhealth.com

MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. It also operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients’ mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment.

MedX Health Corp Fundamentals Summary

How do MedX Health's earnings and revenue compare to its market cap?
MDX fundamental statistics
Market capCA$22.96m
Earnings (TTM)-CA$3.15m
Revenue (TTM)CA$367.99k

62.4x

P/S Ratio

-7.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MDX income statement (TTM)
RevenueCA$367.99k
Cost of RevenueCA$244.84k
Gross ProfitCA$123.15k
Other ExpensesCA$3.27m
Earnings-CA$3.15m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.012
Gross Margin33.47%
Net Profit Margin-855.63%
Debt/Equity Ratio-81.2%

How did MDX perform over the long term?

See historical performance and comparison